Annual Report 2012 Active Biotech AB (publ)
(Thomson Reuters ONE) -
Active Biotech's Annual Report 2012 (in Swedish) is now available for download
at www.activebiotech.com. The English version will be available within short.
The Annual Report will only be digitally distributed.
Lund, April 15, 2013
Active Biotech AB (publ)
Tomas Leanderson
President & CEO
For further information, please contact:
Hans Kolam
CFO
Tel +46 (0)46 19 20 44
Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company with
focus on autoimmune/inflammatory diseases and cancer. Projects in pivotal phase
are laquinimod, an orally administered small molecule with unique
immunomodulatory properties for the treatment of multiple sclerosis, tasquinimod
for prostate cancer and ANYARA primarily for the treatment of renal cell cancer.
In addition, laquinimod is in Phase II development for Crohn's and Lupus. The
company also has one additional project in clinical development, the orally
administered compound 57-57 for Systemic Sclerosis. Please visit
www.activebiotech.com for more information.
Active Biotech AB (Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund
Tel: +46 46 19 20 00
Fax: +46 46 19 11 00
Active Biotech is required under the Financial Instruments Trading Act to make
the information in this press release public. The information was submitted for
publication at 10:00 a.m. CET on April 15, 2013.
Annual Report 2012 Active Biotech AB (publ):
http://hugin.info/1002/R/1692964/556338.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Active Biotech via Thomson Reuters ONE
[HUG#1692964]
Unternehmensinformation / Kurzprofil:
Datum: 15.04.2013 - 10:01 Uhr
Sprache: Deutsch
News-ID 248866
Anzahl Zeichen: 2294
contact information:
Town:
LUND
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 148 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Annual Report 2012 Active Biotech AB (publ)"
steht unter der journalistisch-redaktionellen Verantwortung von
Active Biotech (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
